"Theranostic Nanomedicine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An integrated nano-scale approach to MEDICINE which involves concurrent diagnosis, drug delivery, therapy, and monitoring of therapeutic response.
Descriptor ID |
D000068936
|
MeSH Number(s) |
E01.894 E02.921 H01.603.600.500 H02.403.845 J01.897.520.600.600.500
|
Concept/Terms |
Theranostic Nanomedicine- Theranostic Nanomedicine
- Nanomedicine, Theranostic
- Nanomedicines, Theranostic
- Theranostic Nanomedicines
|
Below are MeSH descriptors whose meaning is more general than "Theranostic Nanomedicine".
Below are MeSH descriptors whose meaning is more specific than "Theranostic Nanomedicine".
This graph shows the total number of publications written about "Theranostic Nanomedicine" by people in this website by year, and whether "Theranostic Nanomedicine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2016 | 1 | 0 | 1 |
2017 | 9 | 5 | 14 |
2018 | 6 | 5 | 11 |
2019 | 2 | 5 | 7 |
2020 | 1 | 5 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Theranostic Nanomedicine" by people in Profiles.
-
Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Life Sci. 2021 Aug 01; 278:119580.
-
The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing. Life Sci. 2021 Jun 01; 274:119289.
-
Advanced Nanomaterials for Preparedness Against (Re-)Emerging Viral Diseases. Adv Mater. 2021 Nov; 33(47):e2005927.
-
A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease. Nucl Med Commun. 2020 09; 41(9):837-840.
-
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials. J Control Release. 2020 12 10; 328:112-126.
-
Vesicular drug delivery systems as theranostics in COVID-19. Future Med Chem. 2020 09; 12(18):1607-1609.
-
Optical theranostics and treatment dosimetry for COVID-19 lung complications: Towards increasing the survival rate of vulnerable populations. Photodiagnosis Photodyn Ther. 2020 09; 31:101892.
-
COVID-19: Progress in diagnostics, therapy and vaccination. Theranostics. 2020; 10(17):7821-7835.
-
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics. 2020; 10(16):7448-7464.
-
Radiomics Analysis of Computed Tomography helps predict poor prognostic outcome in COVID-19. Theranostics. 2020; 10(16):7231-7244.